Академический Документы
Профессиональный Документы
Культура Документы
EXANTHEMS
• Lesions “outside” the skin
• Rubeola
• Rubella
• Roseola Infantum
• Erythema Infectiosum
• Varicella
• Herpes Zoster
• Hand-Foot-Mouth Disease
Rubeola (Measles)
Etiology Rubeola virus
(Family: Paramyxovirus, Genus: Morbillivirus)
Incubation Period 8-12 days
Mode of Transmission Droplets; indirectly with articles newly contaminated with
respiratory secretions; airborne
Period of 4 days prior to the rash and 4 days after the rash
Communicability appears
Immunity after infection Lifelong
Rubeola (Measles)
STAGE
1 Primary viremia in the reticuloendothelial system
Secondary viremia in body
2 Prodrome: 3-5 days of (3C’s: conjunctivitis, coryza, cough)
Koplik spots:
- whitish lesions in buccal mucosa opposite the molar
-pathognomonic of measles, found at the soft or hard palate 24-48 hrs
only
3 Exanthematous Stage: antibody formation, viral replication, rashes appear
Final / 6th day, may show desquamation
Recovery
stage
Rubeola (Measles)
• Fever (rash simultaneously appears w/fever)
– High until the middle of the course of the illness
• Rash appears (4th day) at the peak of high-grade fever
• Maculopapular rash
– Appears 1st in the face (includes hairline and neck)
and tends to go down to the chest and abdomen in
24 hours
Rubeola (Measles)
• When the rash appears on the feet, the
rash on the face fades and leaves a
branny desquamation
• Koplik spots
• Cough – last to disappear
Rubeola (Measles)
Diagnosis
•Serologic: Identification of IgM – appears 1-2
days after rash appears and detectable until 1
month
•Four-fold rise in IgG antibodies in specimens
collected 2-4 weeks interval
Rubeola (Measles)
• IgIM given to exposed child within 5 days
of exposure; given to
immunocompromised child given every 4
weeks until epidemic subsides
• Live measles vaccine, 3 months after,
provided child is 9 months and above
• Active immunization
Rubeola (Measles)
• Supportive treatment
• Antipyrectics for fever control
• Oral hydration
Rubeola (Measles)
• Immunization is given subcutaneously
• Given at 9 mos (6 mos if w/outbreaks)
• MMR (1st dose: 12-15 months, 2nd dose: 4-
6 yrs old)
Rubella (German Measles)